Document Detail


Effect of bronchodilators on airway resistance in ventilator-dependent neonates with chronic lung disease.
MedLine Citation:
PMID:  2956405     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Using a noninvasive passive flow volume technique to measure respiratory system resistance (Rrs) and compliance (Crs), the effects of two inhaled bronchodilators, salbutamol (beta 2-agonist) and ipratropium bromide (muscarinic blocker), were studied in 17 premature infants ranging in age from 19 to 103 days. All were ventilator dependent with chronic lung disease. The pretreatment Rrs was high (range 0.15 to 0.27 cm H2O X ml-1 X sec). After administration of salbutamol, the mean group Rrs decreased 24% +/- 11% (mean +/- SD), and Crs increased significantly, 17% +/- 21%. The response to ipratropium bromide in five infants did not differ significantly from their responses to salbutamol. Nebulized saline solution had no bronchodilator effect in five infants. These results suggest that in infants with early and late chronic lung disease, bronchospasm can be partially alleviated by inhaled bronchodilators.
Authors:
R A Wilkie; M H Bryan
Related Documents :
16326985 - Surfactant composition and function in a primate model of infant chronic lung disease: ...
8469815 - Whole-body plethysmography in the clinical assessment of infants with bronchopulmonary ...
8112445 - Lung function in awake healthy infants: the first five days of life.
1118085 - Comparison of the fetogram and l/s ratio for fetal maturity.
20835585 - Prevalence and severity of wheezing in the first year of life.
6536405 - Corrective casting in infants.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of pediatrics     Volume:  111     ISSN:  0022-3476     ISO Abbreviation:  J. Pediatr.     Publication Date:  1987 Aug 
Date Detail:
Created Date:  1987-09-10     Completed Date:  1987-09-10     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375410     Medline TA:  J Pediatr     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  278-82     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Airway Resistance / drug effects*
Albuterol / therapeutic use
Bronchodilator Agents / therapeutic use*
Bronchopulmonary Dysplasia / drug therapy*,  physiopathology
Chronic Disease
Drug Evaluation
Humans
Infant
Infant, Newborn
Infant, Premature
Ipratropium / therapeutic use
Lung Compliance / drug effects
Nebulizers and Vaporizers
Ventilators, Mechanical*
Chemical
Reg. No./Substance:
0/Bronchodilator Agents; 18559-94-9/Albuterol; 60205-81-4/Ipratropium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Assignment of proteins to human chromosome 21 using two-dimensional gel electrophoresis and somatic ...
Next Document:  Role of vasopressin in the cardiovascular effects of LY171555, a selective dopamine D2 receptor agon...